跳至主要内容
临床试验/CTRI/2018/07/014947
CTRI/2018/07/014947招募中3 期

Pregnancy-Related Interventions in Mothers at Risk for gestational Diabetes in Asian India and Low and middle income countries (PRIMORDIAL Study)

Department of Biotechnology Newton Fund Global Research Programme0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Eligible pregnant women should be
  • (1) aged 18 years or older
  • (2) Gestational age 16 weeks or lesser
  • (3) Not currently on any medications (except iron, calcium or folic acid supplements, thyroxine supplement for hypothyroidism, low dose aspirin for pre-eclampsia)
  • (4) Meet at least one of the following criteria that qualifies them as â??high-riskâ??: for GDM
  • Booking BMI >=25kg/m2,
  • Age >=25 years,
  • First-degree relative with diabetes,
  • Previous pregnancy with GDM and/or pre- eclampsia/eclampsia,
  • Previous pregnancy with large baby (>=3.5kg),
  • History of PCOD/impaired fasting glucose)

排除标准

  • Women will be excluded if they meet one or more of the following criteria
  • (1) GDM diagnosed prior to screening visit based on IADPSG criteria or documented raised HbA1C, i.e., either fasting glucose >=5.1 mmol/L or 1h glucose >=10.0 mmol/L or 2h glucose >=8.5 mmol/L, or a documented HbA1c of >=6.5% at first booking
  • (2) History of pre-gestational diabetes
  • (3) Multiple gestation in the current pregnancy
  • (4) History of severe hyperemesis in the first trimester
  • (5) Uncontrolled pre-gestational or gestational hypertension (BP >150/100 mmHg) or currently on treatment hypertension
  • (6) History of recurrent (>=2) first trimester spontaneous abortions or stillbirths
  • (7) Previous child born with congenital anomalies
  • (8) History of significant ante- or post-partum haemorrhage in the previous pregnancy.
  • (9) Pregnancy following in-vitro fertilization or any assisted reproductive technology
  • (10) Previous or current psychiatric illness on medication, epileptic seizures or on antiepileptic medication
  • (11) women meeting absolute contraindications for physical activity during pregnancy as recommended by the ACOG such as heart disease, restrictive lung disease, incompetent cervix/cerclage, pregnancies at risk for premature labour, gestational hypertension (BP >150/100 mmHg), severe anemia.
  • (12) Physical disability to PA and/or known lactose intolerance

研究者

发起方
Department of Biotechnology Newton Fund Global Research Programme

相似试验